Background and History of Prostate Cancer

For example, age is the biggest factor. We all know that as men age and get older they run a higher chance of their prostate enlarging and developing cancer. Family history and race are also the other two big ones. If people in your immediate family have had the cancer, then you run a higher risk of contraction because you’re already genetically predisposed to getting prostate cancer. Also, African American men are more likely to be diagnosed with the cancer, with white and Hispanic men following behind. According to the CDC, from the years 1999-2013, black men had higher mortality and contraction rates than men of other races and ethnicities.1 Hormones are also a risk factor; should the male be producing a lot of testosterone could put him at risk.

Prostate Cancer is a disease in which there is an uncontrolled growth of cells that lines the ducts of the prostate gland. The abnormal cells can spread throughout the prostate and nearby organs, such as the seminal vesicles. If not caught early they can spread (metastasized) to other organs of the body through the lymph or blood stream. (“...Treatment...” 13) Prostate Cancer can be like a silent killer. Some may show signs and symptoms of this disease while others may not. Some symptoms may include frequent urination, blood in the urine or semen, delayed or slowed start of urinary stream and dribbling or leakage of urine. Diagnosis testing for Prostate Cancer are digital

An indicator of the future course of prostate cancer is predicted by tumor grade and stage. The age of the patient does not seem to play a role in the rate at which tumors spread and become life threatening. At the present moment, determining the stage of prostate cancer without surgery is unreliable. As soon as the cancer spreads to bones or other organs, hormonal treatments can only achieve temporary remissions often measured in months.

In the United States, there are estimated 1.3 million cases of cancer diagnosed each year showing about 570,280 annual deaths. The most commonly encountered cancers include those of the prostate, breast, lung, colon, and rectum. Lung cancer has shown increased fatality rate and is responsible for approximately 160,000 deaths each year in the United States alone. [3].

Prostatic carcinoma is the most commonest threat in men and the moment driving cause of cancer passing in Western populaces.

It is estimated that in 2016 there will be about 180,890 new cases and 26,120 deaths from prostate cancer. It is also known that prostate cancer is the second most common cancer and the second leading cause of cancer death in American men, behind only lung cancer (1).

PSA is a biomarker that is regularly used clinically for screening and diagnosis of prostate cancer. It was discovered in 1972 while trying to find a substance in seminal fluid that would aid in the research of medical cases. Papsidero and associates measured PSA quantitatively in the blood in 1980, which was stated to be a clinical use as a marker for prostate cancer. PSA exists in small quantities in the serum of normal men, and it is raised higher in the presence of prostate cancer and other prostate ailments [8]. Prostate cancer can also be present in the whole absence of a raised PSA level. PSA expresses androgen dependent and so it is less sensitive in older population. The limitations of PSA as biomarker

Prostate cancer is considered as the most commonly diagnosed cancer in men, in the U. S and most cases of prostate cancer have a good prognosis. Some of these cases can be aggressive and the death-rate is assessed to be 2.8%. The Prostate-specific antigen (PSA) test is used for screening for prostate cancer, to aid early detection and treatment.

A man’s age is what will put him at higher risk for prostate cancer. Men who are at higher risk are men between ages 40 and 50 years old. It is very rare for a man to be diagnosed with prostate cancer but as it is not common to be diagnosed with prostate cancer it is more likely to be diagnosed with it after the age of 50. Let it be known that more than 220,000 men will be diagnosed this year with prostate cancer, and over 20,000 men will lose their life from it. These statistics have been increasing over the years because there is no answer in what causes prostate cancer.

Penile cancer sounds like a joke. It’s not. Penile cancer is still a cancer, and by being a cancer, it can and probably will, be lethal to your health. There are multiple types of penile cancers, each one varying in seriousness. These types of cancers include Melanoma, a cancer found in sun-exposed skin, and sarcoma, a cancer that develops in sorts of blood vessels, smooth muscles, and other connective tissue cells in the penis. Penile cancer is serious, albeit rare, taking up only 0.1% of cancer induced deaths. The mortality rate for penile cancer is 25 to 33%.

About 1 man in 7 will be diagnosed with prostate cancer during his lifetime. Prostate cancer occurs mainly in older men about 6 cases in 10 are diagnosed in men aged 65 or older, and it is rare before age 40. The average age at the time of diagnosis is about 66. The American cancer association estimated about 220,800 new cases of prostate cancer and about 27,540 deaths this 2015. Prostate cancer occurs in African-American men of African ancestry than in men of other races. African-American men are also more than twice as likely to die of prostate cancer as white men. It also occurs less often in Asian-American and Hispanic/Latino men than in non-Hispanic whites. The reasons for these racial and ethnic differences are not clear. Although prostate cancer can be a serious disease, most men diagnosed with prostate cancer do not die from

Cancer. One word, a million different emotions. Cancer is a term used to describe a group of diseases in which abnormal cells divide and invade other tissues at an uncontrollable rate. Cancer cells rapidly travel through blood and lymph systems to other parts of the body. With over 100 different types of cancers this year alone over 500,000 Americans are expected to die from cancer, making it the second leading cause of death in the US. (TLCF,2014- Thomas Latimer Cancer Foundation) Among the vast forms of cancer, prostate cancer is the second most common cancer in American men after skin cancer. Prostate cancer affects males as it is found in the prostate gland an organ found in the male reproductive system. Prostate cancer has many faucets

The disease epidemiology has also been researched in different sub-populations. In a cohort of men that underwent screening for prostate cancer, Peyronie's disease prevalence was 8.9%. Significantly higher prevalence of 15.9% is seen in men after radical prostatectomy. Furthermore, in men evaluated for erectile disfunction, Peyronie's disease was found in 7.9% of individuals. Diabetes has also been identified as a potential risk factor for the development of this condition.

When we had a diseases or diagnoses, we tend to seek treatments and try to cure it as soon as possible. However, what if there is no reliable treatment or nearly no treatment and the only things is to do research. Life can be really difficult and no one wants any sickness or diagnosed with such a disease like cancer. Prostate Cancer is a known cancer that happen to men only and a lot of men in the U.S had it. The part that happens to male’s reproductive system and it is a gland found in the most private area of a men. Moreover, it is located in front of the rectum and under the bladder where it grows slowly. First, prostate cancer really affect men who diagnosed with it and we need to understand it first to be able to solve it. Next,

While many illnesses and diseases are well understood, prostate cancer is one of the remaining cancerous conditions that is shrouded in misunderstanding. There are several main reasons for this, not the least of which is that men as a group, simply do not want to deal with this very common no cancerous condition.